About Outlook Investments Leadership Philanthropy Contact
Yanko Holdings, LLC

A telecom entrepreneur
and a drug discovery scientist.

That is our actual edge.

Felix has spent 25 years building cloud communications businesses. Zina is a PhD chemist who develops cancer treatments. We invest in industries where we still work, which means founders get a partner who understands their problems from the inside.

25+
Years combined industry experience
3
Core investment sectors
Single-Family Office
Investing our own capital. No outside investors.
Telecommunications Biotechnology Real Estate Single-Family Office Operator Investors Laramie, Wyoming Patient Capital BlueTree Allied Angels Telecommunications Biotechnology Real Estate Single-Family Office Operator Investors Laramie, Wyoming Patient Capital BlueTree Allied Angels

Who We Are

Our own capital.
Our own conviction.

Yanko Holdings is a single-family office run by Felix Yanko and Zina Ribkovskaia. Husband and wife, and co-investors. We invest our own money, which means every decision reflects genuine judgment, not allocation pressure.

No outside stakeholders, no quarterly redemption cycles, no return targets set by someone else. We invest in industries where we have deep working knowledge, on our own terms and timeline.

Both originally from Chișinău, Moldova. Immigrants who found opportunity here, and believe in making that possible for others.

That combination of telecom operating experience and pharmaceutical science is rare in investing. We think it matters when founders need a partner who understands the real challenges in their space.

"When it is your own money on the line, you ask different questions. You slow down. You do not invest to feel like you are doing something."
Felix Yanko, Principal

Current Perspectives

What We're Watching

Three areas where our thinking is focused. Not investment advice, just where our attention is and why.

Telecommunications

AI is changing how businesses buy and use communications infrastructure

Voice, messaging, and cloud phone systems are being rebuilt around AI-native workflows. We are watching how incumbents respond and where genuine new businesses can be built on top of the shift.

Biotechnology

Protein degradation as a therapeutic platform is still early

Targeted protein degraders represent a fundamentally different way to address diseases. The science is advancing faster than capital formation in this area, which creates interesting moments.

Real Estate

Rate normalization is creating dislocated asset values in select markets

Our background gives us a natural comfort with international markets. We are patient buyers in select European and emerging markets, as well as domestically, where we can hold through the cycle with a long-term view.

Investment Criteria

Where We Invest

We are not generalists. Each sector we pursue is one where at least one of us has operated, built, or worked at a scientific level. That specificity shapes what we look for and how we evaluate deals.

Telecom

Cloud Communications

Companies building SaaS products, infrastructure, or AI-powered tools for business communications. Felix has founded and operated in this space for over two decades.

We look for

SaaS or API-first business model
Recurring revenue with strong net retention
Founders with prior telecom or enterprise software experience
Defensible integrations into existing workflows
Biotech

Drug Discovery & Development

Early-stage companies developing novel therapeutics, particularly in oncology, targeted protein degradation, and precision medicine platforms. Zina contributes deep scientific diligence here.

We look for

Differentiated mechanism of action with published evidence
Strong scientific founders with relevant domain expertise
Clear path to IND or clinical milestone within 18-36 months
Supportive IP position around core assets
Real Estate

Residential & Commercial, with an International Lens

Direct ownership and selective co-investments in residential and light commercial real estate. We have a natural preference for international markets — particularly in Europe — where our background gives us cultural and market familiarity that most U.S.-based investors lack.

We look for

International markets, particularly Europe, where we have firsthand familiarity
Assets with identifiable operational value-add opportunities
Conservative leverage and visible cash flow from day one
A trusted local operating partner on the ground

The Team

Two people.
Deep expertise.

Felix Yanko

Felix Yanko

Principal -- Telecommunications & Technology

Felix has spent over 25 years building and operating technology companies in the cloud communications industry. He is the President and co-founder of Voiply LLC, a VoIP and cloud phone service provider. He holds degrees in Computer Science from the University of Pittsburgh and the University of Rhode Island, and is a member of BlueTree Allied Angels.

VoIP / Cloud Comms SaaS Operations Angel Investing 25+ Years Industry
LinkedIn ↗
Zina Ribkovskaia

Zina Ribkovskaia

Principal -- Biotechnology & Drug Discovery

Zina is a PhD chemist and drug discovery scientist with deep experience across academic research, biotech, and pharmaceutical development. Her career spans NIH SBIR-funded research, peer-reviewed publications, and hands-on work in oncology and precision medicine. She is a member of BlueTree Allied Angels and provides scientific diligence for the firm's life sciences investments.

PhD Chemistry Drug Discovery Oncology NIH Research
LinkedIn ↗

How We Think

Our Approach

01

We only invest where we have an edge

Every investment we make is in a sector where at least one of us has operated. We are not generalists who believe curiosity is a substitute for experience.

02

We move slowly on purpose

Our capital has no expiration date. We do not face redemption pressure or fund lifecycle constraints. That patience is a genuine competitive advantage when most capital is in a hurry.

03

We are useful, not just present

We take board seats and advisory roles where we can genuinely contribute, because founders in our sectors benefit from partners who have lived through the same problems.

04

We do not syndicate noise

We prefer smaller, focused syndicates with aligned time horizons over large rounds assembled primarily to distribute risk.

"Most investors in our sectors are financially sophisticated but operationally distant. We are the opposite."

Felix built and sold multiple communications businesses. Zina has done bench science, managed research programs, and navigated the pharmaceutical development environment firsthand.

When founders pitch us, they are talking to people who have done the job. That changes the conversation.

Giving Back

What We Support

Our giving is an extension of our values, not a line item or a PR effort. We support causes connected to science, education, and communities we care about.

01

STEM Education

We support programs that give students from underrepresented backgrounds meaningful access to computer science and scientific research opportunities early in their education.

02

Cancer Research

Zina's scientific background informs our giving here. We support early-stage research initiatives that may not yet attract large institutional funding but represent genuine scientific progress.

03

Local Community Development

We support local community initiatives that build long-term economic opportunity for working families and small business owners.

"We believe that giving, like investing, works best when it comes from a genuine understanding of the problem, not from a distance."
Zina Ribkovskaia, Principal

Get in Touch

Let's connect.

If you are building something in our focus areas, we are always willing to have a conversation. We do not respond to every inquiry, but we read everything.

Phone(307) 555-1847
Address210 E Custer St
Laramie, WY 82070

We do not share or sell your information. See our Privacy Policy for details.

Thank you -- we will be in touch.